2 p.Gut microbiota is involved in obesity,
metabolic syndrome and nonalcoholic fatty liver disease
(NAFLD). Quercetin may modulate the intestinal microbiota
composition, suggesting therapeutic potential in NAFLD. The
present study aims to establish the role of gut microbiota imbalance
in obesity-related NAFLD development in patients and in
an in vivo model and to investigate benefits of experimental
treatment with quercetin. Resumen de un trabajo resultado del proyecto de investigación financiado por la Consejería de Educación de la Junta de Castilla y León (referencia LE063U16)S